Performance analysis of Telomir Pharmaceuticals (TELO)
Annual Return
Since Feb 9, 2024, TELO has had an average annual return of -50.00%, underperforming the benchmark SPY, which returned +18.86% annual.
| 2026 | 2025 | 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -30.90% | -67.72% | -17.60% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -14.29% | +11.40% | +2.36% | +7.69% | -7.14% | -1.54% | -28.20% | -30.90% | |||||
| 2025 | +17.96% | -17.70% | -19.25% | -21.05% | -23.73% | -35.73% | +49.60% | -29.41% | +5.30% | +12.23% | -14.10% | -0.75% | -67.72% |
| 2024 | +81.40% | -43.22% | +28.54% | -8.61% | -20.50% | -24.95% | +45.15% | +22.52% | -36.76% | -1.97% | +3.52% | -17.60% |
Drawdown analysis of Telomir Pharmaceuticals (TELO)
The maximum drawdown for the TELO was -92.28%, occurring on Jul 20, 2026. This drawdown has not yet recovered.
The current TELO drawdown is -92.28%.
Since Feb 9, 2024 TELO has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -92.28% | Feb 14, 2024 | 607 | Jul 20, 2026 | Ongoing | Ongoing | Ongoing |